Research
Molecular
Molecular engineering strategies have advanced biologic therapies for diabetes by optimizing therapeutic stability, pharmacokinetics, and delivery.
Practitioners can leverage molecular engineering to enhance diabetes therapies.
StrongSupportsmedium confidence
Biologic therapies for diabetes have advanced significantly through molecular engineering strategies that optimize therapeutic stability, pharmacokinetics, and delivery.
Why this rating
The abstract presents a comprehensive review of advancements in diabetes therapies.
Source
Molecular engineering of designer diabetes therapeutics
Emily L. DeWolf et al. · Journal of Controlled Release · 2026
DOI 10.1016/j.jconrel.2026.114705
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →